ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study

L. Karimi (Rotterdam, Netherlands), L. Lahousse (Ghent, Belgium), M. Ghanbari (Rotterdam, Netherlands), N. Terzikhan (Rotterdam, Netherlands), A. Uitterlinden (Rotterdam, Netherlands), J. Van Der Lei (Rotterdam, Netherlands), G. Brusselle (Ghent, Netherlands), B. Stricker (Rotterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands)

Source: International Congress 2019 – Genes and environment
Session: Genes and environment
Session type: Poster Discussion
Number: 5389
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Karimi (Rotterdam, Netherlands), L. Lahousse (Ghent, Belgium), M. Ghanbari (Rotterdam, Netherlands), N. Terzikhan (Rotterdam, Netherlands), A. Uitterlinden (Rotterdam, Netherlands), J. Van Der Lei (Rotterdam, Netherlands), G. Brusselle (Ghent, Netherlands), B. Stricker (Rotterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands). ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study. 5389

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: